The release of CXCL2 activated CXCR2 and the blockade of CXCR2 signaling hindered macrophage-like cell migration that was triggered by programmed cell death 10 (PDCD10)-overexpressed glioblastoma cells (Zhang et al. 2021). The gene discussed is CXCL2; the disease is glioblastoma.